<--- Back to Details
First PageDocument Content
Astellas Pharma / Nikkei 225 / Antiandrogens / Tacrolimus / Enzalutamide / OSI Pharmaceuticals / Regadenoson / Wholesaling / Erlotinib / AmerisourceBergen / Pharmaceutical industry in China / Cardinal Health
Date: 2016-03-14 02:16:38
Astellas Pharma
Nikkei 225
Antiandrogens
Tacrolimus
Enzalutamide
OSI Pharmaceuticals
Regadenoson
Wholesaling
Erlotinib
AmerisourceBergen
Pharmaceutical industry in China
Cardinal Health

Authorized Distributors of Record Below is a listing of the Authorized Distributors of Record (ADRs) for Astellas Pharma US, Inc. and OSI Pharmaceuticals, LLC, in accordance with 21 C.F.R. § d). If you have quest

Add to Reading List

Source URL: www.astellas.us

Download Document from Source Website

File Size: 279,07 KB

Share Document on Facebook

Similar Documents

Page 1 of 2  M O N T H L Y F A C T S H E E T | AP R I LDSBI Japan Equity Fundamental Active (I) JPY

Page 1 of 2 M O N T H L Y F A C T S H E E T | AP R I LDSBI Japan Equity Fundamental Active (I) JPY

DocID: 1rqQJ - View Document

Annex.3  Annex 3. Outline of JPX-Nikkei Index 400(Please refer to the guidebook for more details.) Name No. of Constituents

Annex.3 Annex 3. Outline of JPX-Nikkei Index 400(Please refer to the guidebook for more details.) Name No. of Constituents

DocID: 1rqsR - View Document

Page 1 of 2  M O N T H L Y F A C T S H E E T | AP R I LLanguage: English

Page 1 of 2 M O N T H L Y F A C T S H E E T | AP R I LLanguage: English

DocID: 1r2y1 - View Document

Toyota and safety ETCS PIN Talk in Denmark René Mouritsen General Manager, Toyota Danmark A/S 30 April 2012

Toyota and safety ETCS PIN Talk in Denmark René Mouritsen General Manager, Toyota Danmark A/S 30 April 2012

DocID: 1qWBl - View Document

Contribution to Academic Study and Research for the Future      Index

Contribution to Academic Study and Research for the Future     Index

DocID: 1qT3z - View Document